Last reviewed · How we verify

NCT04702061

Comparison of Erector Spina Plane Block and Thoracic Epidural Block

Completed NA Last updated 20 April 2021
What this trial tests

NA trial testing Erector spina plane block before general anaesthesia in Breast Neoplasms in 20 participants. Completed in 31 March 2021.

Timeline
11 January 2021
Primary endpoint
31 March 2021
31 March 2021

Quick facts

Lead sponsorInonu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment20
Start date11 January 2021
Primary completion31 March 2021
Estimated completion31 March 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 70, female only, with Breast Neoplasms or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomised controlled and double-blind study, is to compare the effects of erector spinae plane (ESP) and thoracic epidural (TEA) blocks on peri-operative hemodynamics and analgesia in patients undergoing unilateral mastectomies due to malignancy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of sympathetic block and hemodynamic effects of erector spinae plane block and thoracic epidural analgesia in breast surgery: a randomised controlled trial.
    Kurada G, Erdoğan Kayhan G, Şanal S, Onay M, et al · · 2026 · PMID 41691173 · DOI 10.1186/s12871-026-03694-2

Verify or expand the search:

Other recruiting trials for Breast Neoplasms

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04702061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing